MO

Micah Onyekachi Onyeibor

Director Director DIN 02524397
DIN 02524397 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2007
Shareholding value •••• Premium profile

About Micah Onyekachi Onyeibor

Data last updated:

Micah Onyekachi Onyeibor was a Director at Miral Pharmaceuticals Private Limited (2012–2019) and Director at Emzor Exports Private Limited (2007–2019). The companies operate in Pharma and Trading.

DIN 02524397
Primary Designation Director
Industry Pharma
First Appointment 11 May 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20122012Strike Off
Emzor Exports Private Limited U51909GJ2007PTC050786
Director11 May 20072007₹23.6 Lakh (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Miral Pharmaceuticals Private Limited
Emzor Exports Private Limited
Premium access

Shareholding and investment profile for Micah Onyekachi Onyeibor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Micah Onyekachi Onyeibor

Micah Onyekachi Onyeibor was first appointed on 11 May 2007 as Director at Emzor Exports Private Limited. The most recent appointment on record is 28 Mar 2012 at Miral Pharmaceuticals Private Limited.

Micah Onyekachi Onyeibor held 2 earlier board appointments: Miral Pharmaceuticals Private Limited (Director, 28 Mar 2012 to 13 Apr 2019); Emzor Exports Private Limited (Director, 11 May 2007 to 15 Apr 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available